You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Liquid biopsy: A breakthrough technology in early cancer screening
- 2. Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review
- 3. Nanostics Launches Clinical Utility Study for Its AI-Powered ClarityDX Prostate Test to More Accurately Identify Aggressive Prostate Cancer
- 4. Liquid Biopsy in Cancer Diagnostics Market to Grow at a CAGR of ~17% by 2032 with Advancements in Non-Invasive Testing | DelveInsight
- 5. Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
- 6. Liquid biopsy: A breakthrough technology in early cancer screening
- 7. Gilead reports topline data from Phase III trial of Trodelvy combo therapy
- 8. Most Women Are Comfortable With AI-Assisted Mammography
- 9. Solid subtype of adenoid cystic carcinoma of the breast with multiple distant metastases: a case report and literature review
- 10. Development and validation of a preoperative magnetic resonance imaging-based and machine learning model for the noninvasive differentiation of intracranial glioblastoma, primary central nervous system lymphoma and brain metastases: a retrospective analysis
Last updated at 5:54 GMT
Hot News Makers
Health/Pharma Companies
-
156206.17
-
54588.63
-
51789.21
-
50329.72
-
23054.56
-
16131.87
-
13045.33
-
12388.47
-
11477.55
-
8630.72
Drugs, Treatments, Trials
-
23759.14
-
19556.28
-
16296.90
-
10891.82
-
6401.06
-
5778.30
-
5731.45
-
3716.74
-
3284.41
-
2946.72
Last updated at 5:10 GMT
